...0年 acute leukemia,AL)患者化疗前后血浆中组织因子(tissiue factor,TF)及组织因子途径抑制物(tissue factor pathway inhibitor,TFPI)的含量变化,探讨血浆TF及TFPI在AL病情进展、疗效观察、预后判断中的意义,为AL患者发生凝血功能..
基于4个网页-相关网页
目的观察原发性高血压患者血浆组织因子途径、组织因子途径抑制物的变化及用依那普利、特拉唑嗪降压治疗后上述指标的变化。
Objective to observe the changes of tissue factor pathway (TFP) and tissue factor pathway inhibitor (TFPI) in essential hypertension and study the effects of enalapril and terazosin.
结果发现：外源性的组织因子途径抑制物(TFPI)可使PT及APTT延长。
The results showed that PT and APTT were prolonged by exogenous TFPI.
目的：研究血浆组织因子途径抑制物（TF PI） 抗原含量及活性对卵巢癌患者的临床意义。
Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor (TFPI) in ovarian cancer.
应用推荐